Department of Ophthalmology, Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea.
Department of Ophthalmology and Inha Vision Science Laboratory, Inha University School of Medicine, Incheon, South Korea.
Cont Lens Anterior Eye. 2018 Oct;41(5):430-435. doi: 10.1016/j.clae.2018.06.002. Epub 2018 Jun 27.
We aimed to determine the long-term effects of intense pulsed light (IPL) treatment in rosacea-associated meibomian gland dysfunction (MGD).
We enrolled 17 rosacea subjects with moderate and severe MGD who underwent four IPL sessions at 3-week intervals and were followed up for 12 months. The subjects underwent clinical examinations at baseline (first IPL) and at 3 (second), 6 (third), 9 (fourth), and 12 weeks, as well as 6 and 12 months, after baseline. Ocular surface parameters, including the Ocular Surface Disease Index (OSDI), tear break-up time (TBUT), staining score, and noninvasive Keratograph tear break-up time (NIKBUT), as well as meibomian gland parameters, including the lid margin vascularity and meibum expressibility and quality, were evaluated.
All ocular surface and meibomian gland parameters for all subjects exhibited significant changes from baseline to the final examination (Friedman, P < 0.050 for all). In particular, improvements in the lower lid margin vascularity, meibum expressibility and quality, and ocular symptoms persisted up to the final examination (Wilcoxon, P < 0.050 for all). However, the improvements of TBUT, staining score, and NIKBUT after IPL were not maintained at 6 and 12 months after baseline.
In rosacea-associated MGD, four IPL treatments at 3-week intervals can improve long-term lid parameters and ocular symptoms without adverse effects.
本研究旨在确定强脉冲光(IPL)治疗酒渣鼻相关睑板腺功能障碍(MGD)的长期效果。
我们纳入了 17 名中重度 MGD 的酒渣鼻患者,他们接受了 4 次 IPL 治疗,间隔 3 周,并在 12 个月内进行随访。在基线(第一次 IPL)以及第 3、6、9、12 周和基线后 6、12 个月进行临床检查。评估眼部表面参数,包括眼表面疾病指数(OSDI)、泪膜破裂时间(TBUT)、染色评分和非侵入性泪膜破裂时间(NIKBUT),以及睑板腺参数,包括眼睑缘血管化和睑脂的分泌及质量。
所有受试者的所有眼部表面和睑板腺参数均从基线到最终检查显示出显著变化(Friedman,所有 P < 0.050)。特别是,下眼睑缘血管化、睑脂分泌和质量以及眼部症状的改善持续到最终检查(Wilcoxon,所有 P < 0.050)。然而,IPL 后 TBUT、染色评分和 NIKBUT 的改善在基线后 6 和 12 个月时并未维持。
在酒渣鼻相关 MGD 中,3 周间隔 4 次 IPL 治疗可以改善长期的眼睑参数和眼部症状,且无不良反应。